Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Campbell's | Mary Alice Dorrance Malone | Director, Ten Percent Owner | Other type of transaction at price $ 27.01 per share. | 06 Jan 2026 | 26,741,880 | 13,218,457 (4%) | 8% | 27.0 | 722,298,179 | Common Stock |
| Applied Digital Corp | Wesley Cummins | Director, CEO; Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 4,500,000 | 4,500,000 | - | - | Performance Stock Units | |
| Beyond Meat Inc | Ethan Brown | President, Chief Exec. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 06 Jan 2026 | 2,095,318 | 23,390,372 (37%) | 3% | 0.9 | 1,957,027 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 06 Jan 2026 | 1,970,000 | 1,970,000 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 06 Jan 2026 | 1,970,000 | 73,574,394 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 06 Jan 2026 | 1,970,000 | 1,970,000 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 06 Jan 2026 | 1,970,000 | 71,634,341 | - | - | Class B Common Stock | ||
| Applied Digital Corp | Wesley Cummins | Director, CEO; Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 1,500,000 | 4,341,329 | - | 0 | Common Stock | |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 19.77 per share. | 06 Jan 2026 | 1,318,300 | 1,773,121 | - | 19.8 | 26,062,791 | Class A Common Stock |
| Health In Tech Inc (Class A) | Tim Johnson | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 1,000,000 | 23,549,741 | - | 0 | Class A Common Stock | |
| Health In Tech Inc (Class A) | Julia Qian | Director, Chief Financial Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 1,000,000 | 9,128,555 | - | 0 | Class A Common Stock | |
| Climb Bio Inc | Aoife M. Brennan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| TuHURA Biosciences Inc | James A. Bianco | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 610,332 | 610,332 | - | - | Options (Right to Buy) | |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.77 per share. | 06 Jan 2026 | 576,959 | 1,196,162 | - | 19.8 | 11,406,479 | Class A Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 562,000 | 562,000 | - | - | Stock Option (right to buy) | |
| Rush Street Interactive Inc (Class A) | Kyle L. Sauers | Chief Financial Officer, President | Grant, award, or other acquisition of securities at price $ 19.77 per share. | 06 Jan 2026 | 533,556 | 1,033,748 | - | 19.8 | 10,548,402 | Class A Common Stock |
| Butterfly Network Inc (Class A) | Jonathan M. Rothberg | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.14 per share. | 06 Jan 2026 | 452,729 | 335,834 | - | 4.1 | 1,874,253 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 06 Jan 2026 | 430,000 | 430,000 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 06 Jan 2026 | 430,000 | 16,297,416 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 06 Jan 2026 | 430,000 | 430,000 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 06 Jan 2026 | 430,000 | 16,297,416 | - | - | Class B Common Stock | ||
| Butterfly Network Inc (Class A) | Jonathan M. Rothberg | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 06 Jan 2026 | 351,617 | 788,563 | - | 4.0 | 1,416,806 | Class A Common Stock |
| Butterfly Network Inc (Class A) | Jonathan M. Rothberg | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.18 per share. | 06 Jan 2026 | 335,834 | 0 | - | 4.2 | 1,404,525 | Class A Common Stock |
| Climb Bio Inc | Perrin Megan Wilson | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Beyond Meat Inc | Lubi Kutua | See remarks. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 06 Jan 2026 | 298,463 | 6,117,679 (9%) | 0% | 0.9 | 278,764 | Common Stock |
| Rush Street Interactive Inc (Class A) | Mattias Stetz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 19.77 per share. | 06 Jan 2026 | 296,692 | 441,498 | - | 19.8 | 5,865,601 | Class A Common Stock |
| TuHURA Biosciences Inc | Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 273,696 | 273,696 | - | - | Options (Right to Buy) | |
| Regenxbio Inc | Curran Simpson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 233,651 | 233,651 | - | - | Stock Options (Right to buy) | |
| Recursion Pharma Inc (Class A) | Blake Borgeson | Director | Sale of securities on an exchange or to another person at price $ 4.36 per share. | 06 Jan 2026 | 220,000 | 6,649,863 | - | 4.4 | 959,200 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Kyle L. Sauers | Chief Financial Officer, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.77 per share. | 06 Jan 2026 | 210,375 | 823,373 | - | 19.8 | 4,159,114 | Class A Common Stock |
| Beyond Meat Inc | Teri L. Witteman | Chief Legal Officer, Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 06 Jan 2026 | 207,407 | 4,171,124 (6%) | 0% | 0.9 | 193,718 | Common Stock |
| Beyond Meat Inc | Dariush Ajami | Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 06 Jan 2026 | 207,349 | 3,005,397 (4%) | 0% | 0.9 | 193,664 | Common Stock |
| Verastem Inc | Michael Glen Kauffman | Director, President of Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Health In Tech Inc (Class A) | Zain Syed Hasan | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 200,000 | 220,000 | - | 0 | Class A Common Stock | |
| APA | John J. Christmann | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 194,666 | 194,666 | - | - | Stock Option Grant | |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | 06 Jan 2026 | 178,482 | 178,482 | - | - | Class A Common Stock | ||
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 17.13 per share. | 06 Jan 2026 | 178,482 | 0 | - | 17.1 | 3,057,522 | Class A Common Stock |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | 06 Jan 2026 | 178,482 | 1,063,790 | - | - | Class B Common Stock | ||
| Rush Street Interactive Inc (Class A) | Paul Wierbicki | Director, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 19.77 per share. | 06 Jan 2026 | 169,074 | 260,779 | - | 19.8 | 3,342,593 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Kyle L. Sauers | Chief Financial Officer, President | Sale of securities on an exchange or to another person at price $ 19.07 per share. | 06 Jan 2026 | 160,067 | 663,306 | - | 19.1 | 3,052,590 | Class A Common Stock |
| Nkarta Inc | Nadir Mahmood | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 160,000 | 160,000 | - | - | Stock Option (right to buy) | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 06 Jan 2026 | 154,479 | 154,479 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 06 Jan 2026 | 154,479 | 11,996,792 | - | - | Class B Common Stock | ||
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | 06 Jan 2026 | 150,000 | 3,149,271 | - | - | Class B Common Stock | ||
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | 06 Jan 2026 | 150,000 | 187,119 | - | 0 | Class A Common Stock | ||
| Nuvectis Pharma Inc | Ron Bentsur | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 150,000 | 3,675,924 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Enrique Poradosu | Chief Science & Business Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 150,000 | 1,806,319 | - | 0 | Common Stock | |
| Nuvectis Pharma Inc | Shay Shemesh | Chief Dev. & Ops. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 150,000 | 1,793,068 | - | 0 | Common Stock | |
| Regenxbio Inc | Curran Simpson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 144,864 | 342,467 (0%) | 0% | 0 | Common Stock | |
| Climb Bio Inc | Susan Altschuller | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 142,500 | 142,500 | - | - | Stock Option (Right to Buy) | |
| Nkarta Inc | Shawn Rose | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 139,000 | 139,000 | - | - | Stock Option (right to buy) | |
| BlackBerry Ltd | John J. Giamatteo | Director, CEO & President, Secure Comm. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 138,493 | 876,541 (0%) | 0% | - | Common Shares | |
| BlackBerry Ltd | John J. Giamatteo | Director, CEO & President, Secure Comm. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 138,493 | 177,112 | - | - | Performance-Based Restricted Share Units | |
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Co-Chief Executive Officer, Ten Percent Owner | 06 Jan 2026 | 137,504 | 137,504 | - | - | Series A Common Stock | ||
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Co-Chief Executive Officer, Ten Percent Owner | 06 Jan 2026 | 137,504 | 69,431,385 | - | - | Series B Common Stock | ||
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Co-Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.92 per share. | 06 Jan 2026 | 135,122 | 2,382 | - | 28.9 | 3,907,728 | Series A Common Stock |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.54 per share. | 06 Jan 2026 | 133,953 | 6,850,724 | - | 0.5 | 72,000 | Common Stock, par value $.001 |
| AnaptysBio Inc | Daniel R. Faga | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 133,400 | 133,400 | - | - | Stock Option (right to buy) | |
| Rush Street Interactive Inc (Class A) | Mattias Stetz | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.77 per share. | 06 Jan 2026 | 131,874 | 309,624 | - | 19.8 | 2,607,149 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Neil Bluhm | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 19.77 per share. | 06 Jan 2026 | 128,866 | 685,521 | - | 19.8 | 2,547,681 | Class A Common Stock |
| Anavex Life Sciences Corp | Christopher U. Missling | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| APA | Stephen J. Riney | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 110,769 | 110,769 | - | - | Stock Option Grant | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.06 per share. | 06 Jan 2026 | 106,169 | 1,863,831 | - | 34.1 | 3,615,798 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.06 per share. | 06 Jan 2026 | 106,135 | 1,863,865 | - | 34.1 | 3,614,693 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.89 per share. | 06 Jan 2026 | 101,865 | 1,762,000 | - | 34.9 | 3,554,579 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.89 per share. | 06 Jan 2026 | 101,831 | 1,762,000 | - | 34.9 | 3,553,362 | Class A Common Stock |
| Compass Inc (Class A) | Ethan Charles Glass | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 101,732 | 101,732 | - | 0 | Class A Common Stock | |
| Mission Produce Inc | Stephen J. Barnard | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 100,723 | 294,202 | - | 0 | COMMON STOCK | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 06 Jan 2026 | 100,000 | 100,000 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 06 Jan 2026 | 100,000 | 3,831,438 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 06 Jan 2026 | 100,000 | 100,000 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 06 Jan 2026 | 100,000 | 4,173,115 | - | - | Class B Common Stock | ||
| Viasat Inc | Mark D. Dankberg | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 40.34 per share. | 06 Jan 2026 | 100,000 | 1,434,993 (2%) | 0% | 40.3 | 4,033,740 | $.0001 par value common stock |
| Climb Bio Inc | Cindy Driscoll | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Compass Inc (Class A) | Scott Wahlers | CFO | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 06 Jan 2026 | 99,986 | 250,073 | - | 12.0 | 1,202,602 | Class A Common Stock |
| AnaptysBio Inc | Daniel R. Faga | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 98,600 | 98,600 | - | - | Restricted Stock Unit | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 94,000 | 416,069 | - | 0 | Common Stock | |
| Nkarta Inc | Nadir Mahmood | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 80,000 | 173,376 | - | 0 | Common Stock | |
| APA | John J. Christmann | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 79,480 | 231,614 | - | - | Restricted Stock / Units | |
| Clover Health Investments Corp (Class A) | Thomas L. Tran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 79,365 | 180,029 | - | 0 | Class A Common Stock | |
| Clover Health Investments Corp (Class A) | William G. Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 79,365 | 597,987 | - | 0 | Class A Common Stock | |
| Clover Health Investments Corp (Class A) | Demetrios L. Kouzoukas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 79,365 | 605,980 | - | 0 | Class A Common Stock | |
| Clover Health Investments Corp (Class A) | Carladenise Armbrister Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 79,365 | 352,592 | - | 0 | Class A Common Stock | |
| Clover Health Investments Corp (Class A) | Anna U. Loengard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 79,365 | 527,456 | - | 0 | Class A Common Stock | |
| Oscar Health Inc (Class A) | Mario Schlosser | Director, President of Technology & CTO | 06 Jan 2026 | 76,962 | 427,142 | - | - | Class A Common Stock | ||
| Oscar Health Inc (Class A) | Mario Schlosser | Director, President of Technology & CTO | Sale of securities on an exchange or to another person at price $ 17.01 per share. | 06 Jan 2026 | 76,962 | 350,180 | - | 17.0 | 1,309,124 | Class A Common Stock |
| Oscar Health Inc (Class A) | Mario Schlosser | Director, President of Technology & CTO | 06 Jan 2026 | 76,962 | 1,455,331 | - | - | Class B Common Stock | ||
| Compass Inc (Class A) | Scott Wahlers | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 76,329 | 389,954 | - | 0 | Class A Common Stock | |
| Rush Street Interactive Inc (Class A) | Paul Wierbicki | Director, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.77 per share. | 06 Jan 2026 | 75,343 | 185,436 | - | 19.8 | 1,489,531 | Class A Common Stock |
| EyePoint Pharma Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 75,133 | 294,346 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 75,133 | 0 | - | - | Restricted Stock Units | |
| Arrowhead Pharma Inc | James Hamilton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 75,000 | 246,958 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Daniel Apel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 75,000 | 176,200 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 75,000 | 547,408 (0%) | 0% | 0 | Common Stock | |
| Regenxbio Inc | Patrick J. Christmas | Chief Strategy & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 73,749 | 215,367 (0%) | 0% | 0 | Common Stock | |
| Regenxbio Inc | Mitchell Chan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 73,749 | 127,717 (0%) | 0% | 0 | Common Stock | |
| Beam Global | George Syllantavos | Director | Grant, award, or other acquisition of securities at price $ 1.75 per share. | 06 Jan 2026 | 71,577 | 112,083 (2%) | 1% | 1.8 | 125,260 | Common Stock |
| Beam Global | Judith F. Krandel | Director | Grant, award, or other acquisition of securities at price $ 1.75 per share. | 06 Jan 2026 | 71,577 | 133,019 (2%) | 1% | 1.8 | 125,260 | Common Stock |
| Beam Global | Anthony L. Posawatz | Director | Grant, award, or other acquisition of securities at price $ 1.75 per share. | 06 Jan 2026 | 71,577 | 202,111 (3%) | 1% | 1.8 | 125,260 | Common Stock |
| BlackBerry Ltd | John J. Giamatteo | Director, CEO & President, Secure Comm. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 71,022 | 0 | - | - | Restricted Share Units | |
| BlackBerry Ltd | John J. Giamatteo | Director, CEO & President, Secure Comm. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 71,022 | 889,579 (0%) | 0% | - | Common Shares | |
| Nkarta Inc | Shawn Rose | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 70,000 | 70,000 | - | 0 | Common Stock | |
| Opus Genetics Inc | Cam S. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 67,000 | 1,991,430 | - | 0 | Common Stock | |
| Regenxbio Inc | Stephen Pakola | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 65,847 | 258,317 (0%) | 0% | 0 | Common Stock | |
| Regenxbio Inc | Craig Malzahn | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 65,847 | 82,194 (0%) | 0% | 0 | Common Stock | |
| Compass Inc (Class A) | Ethan Charles Glass | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 63,583 | 190,750 | - | - | Restricted Stock Unit (RSU) | |
| Nuvectis Pharma Inc | Michael J. Carson | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 61,200 | 200,118 | - | 0 | Common Stock | |
| Sailpoint Inc | Mark D. McClain | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.23 per share. | 06 Jan 2026 | 61,106 | 7,139,202 | - | 19.2 | 1,175,123 | Common Stock |
| BlackBerry Ltd | John J. Giamatteo | Director, CEO & President, Secure Comm. | Sale of securities on an exchange or to another person at price $ 3.88 per share. | 06 Jan 2026 | 57,984 | 818,557 (0%) | 0% | 3.9 | 224,978 | Common Shares |
| Amplify Energy Corp | James G. Frew | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 55,829 | 185,051 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Amplify Energy Corp | James G. Frew | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 55,829 | 96,009 | - | - | Performance Stock Units | |
| Amplify Energy Corp | Daniel Furbee | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 55,829 | 105,067 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Amplify Energy Corp | Daniel Furbee | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 55,829 | 98,909 | - | - | Performance Stock Units | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 78.42 per share. | 06 Jan 2026 | 53,601 | 37,947 | - | 78.4 | 4,203,573 | Class A Common Stock |
| Sailpoint Inc | Mark D. McClain | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.57 per share. | 06 Jan 2026 | 52,799 | 7,034,417 | - | 19.6 | 1,033,335 | Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 77.29 per share. | 06 Jan 2026 | 52,678 | 91,548 | - | 77.3 | 4,071,440 | Class A Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | 06 Jan 2026 | 52,384 | 5,138,234 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | 06 Jan 2026 | 52,384 | 5,085,850 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | 06 Jan 2026 | 52,384 | 5,033,466 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | 06 Jan 2026 | 52,384 | 52,384 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | 06 Jan 2026 | 52,384 | 52,384 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | 06 Jan 2026 | 52,384 | 52,384 (0%) | 0% | - | Class A Common Stock | ||
| Sailpoint Inc | Mark D. McClain | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.90 per share. | 06 Jan 2026 | 51,986 | 7,087,216 | - | 19.9 | 1,034,667 | Common Stock |
| Compass Inc (Class A) | Ethan Charles Glass | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.83 per share. | 06 Jan 2026 | 51,859 | 49,873 | - | 10.8 | 561,633 | Class A Common Stock |
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 06 Jan 2026 | 50,000 | 137,119 | - | 24.3 | 1,214,500 | Class A Common Stock |
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 24.99 per share. | 06 Jan 2026 | 50,000 | 87,119 | - | 25.0 | 1,249,500 | Class A Common Stock |
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 25.99 per share. | 06 Jan 2026 | 50,000 | 37,119 | - | 26.0 | 1,299,500 | Class A Common Stock |
| Compass Inc (Class A) | Scott Wahlers | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 49,936 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Figs Inc (Class A) | Catherine Eva Spear | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.38 per share. | 06 Jan 2026 | 49,734 | 1,857,299 | - | 11.4 | 565,918 | Class A Common Stock |
| APA | Stephen J. Riney | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 45,226 | 132,564 | - | - | Restricted Stock / Units | |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.99 per share. | 06 Jan 2026 | 45,000 | 28,343,585 | - | 16.0 | 719,717 | Class A Commmon Stock |
| APA | Kimberly O. Warnica | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 44,871 | 44,871 | - | - | Stock Option Grant | |
| APA | Ben C. Rodgers | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 44,871 | 44,871 | - | - | Stock Option Grant | |
| APA | Tracey K. Henderson | Executive VP Exploration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 44,871 | 44,871 | - | - | Stock Option Grant | |
| APA | Mark D Maddox | Executive VP - Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 44,871 | 44,871 | - | - | Stock Option Grant | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.82 per share. | 06 Jan 2026 | 43,168 | 661,041 | - | 7.8 | 337,574 | Common Stock |
| Hecla Mining Co. | Kurt D. Allen | VP-Exploration | Sale of securities on an exchange or to another person at price $ 21.89 per share. | 06 Jan 2026 | 42,659 | 216,641 (0%) | 0% | 21.9 | 933,656 | Common Stock |
| Enovix Corp | Ajay Marathe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.68 per share. | 06 Jan 2026 | 42,557 | 933,458 | - | 8.7 | 369,395 | Common Stock |
| Compass Inc (Class A) | Scott Wahlers | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.83 per share. | 06 Jan 2026 | 39,895 | 350,059 | - | 10.8 | 432,063 | Class A Common Stock |
| Regenxbio Inc | Patrick J. Christmas | Chief Strategy & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 39,650 | 39,650 | - | - | Stock Options (Right to buy) | |
| Regenxbio Inc | Mitchell Chan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 39,650 | 39,650 | - | - | Stock Options (Right to buy) | |
| FormFactor Inc | Michael D. Slessor | Director, CEO | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 06 Jan 2026 | 39,606 | 485,995 (0%) | 0% | 65 | 2,574,390 | Common Stock |
| Mission Produce Inc | Stephen J. Barnard | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.79 per share. | 06 Jan 2026 | 38,297 | 255,905 | - | 11.8 | 451,522 | COMMON STOCK |
| Compass Inc (Class A) | Ethan Charles Glass | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 38,149 | 572,250 | - | - | Restricted Stock Unit (RSU) | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 79.23 per share. | 06 Jan 2026 | 37,947 | 0 | - | 79.2 | 3,006,613 | Class A Common Stock |
| Regenxbio Inc | Stephen Pakola | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 35,402 | 35,402 | - | - | Stock Options (Right to buy) | |
| Regenxbio Inc | Craig Malzahn | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 35,402 | 35,402 | - | - | Stock Options (Right to buy) | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.06 per share. | 06 Jan 2026 | 35,392 | 394,608 | - | 34.1 | 1,205,328 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.06 per share. | 06 Jan 2026 | 35,329 | 394,671 | - | 34.1 | 1,203,133 | Class A Common Stock |
| Denali Therapeutics Inc | Ryan J. Watts | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.50 per share. | 06 Jan 2026 | 35,198 | 296,833 (0%) | 0% | 16.5 | 580,767 | Common Stock |
| Hurco Companies Inc | Gregory Volovic | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 34,530 | 164,002 (2%) | 0% | 0 | Common Stock | |
| Mission Produce Inc | Bryan E. Giles | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 34,246 | 169,552 | - | 0 | COMMON STOCK | |
| Broadcom | Hock E. Tan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 347.45 per share. | 06 Jan 2026 | 33,078 | 142,559 (0%) | 0% | 347.5 | 11,493,050 | Common Stock, $0.001 par value |
| Beyond Meat Inc | Jonathan P. Nelson | Chief Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 06 Jan 2026 | 32,208 | 559,287 (0%) | 0% | 0.9 | 30,082 | Common Stock |
| nLIGHT Inc | Scott H. Keeney | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 37.51 per share. | 06 Jan 2026 | 31,748 | 2,285,020 (6%) | 0% | 37.5 | 1,190,867 | Common Stock |
| nLIGHT Inc | Scott H. Keeney | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.15 per share. | 06 Jan 2026 | 31,748 | 2,316,768 (6%) | 0% | 1.1 | 36,510 | Common Stock |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | 06 Jan 2026 | 31,594 | 31,594 | - | - | Class A Common Stock | ||
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 17.58 per share. | 06 Jan 2026 | 31,594 | 0 | - | 17.6 | 555,306 | Class A Common Stock |
| Netskope Inc Ordinary | Sanjay Beri | Director, CEO and Chairman | 06 Jan 2026 | 31,594 | 1,032,196 | - | - | Class B Common Stock | ||
| Sailpoint Inc | Brian Carolan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.57 per share. | 06 Jan 2026 | 30,638 | 1,277,795 | - | 19.6 | 599,619 | Common Stock |
| Beyond Meat Inc | Drew Lufkin | Senior Vice President, Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 06 Jan 2026 | 30,233 | 518,125 (0%) | 0% | 0.9 | 28,238 | Common Stock |
| BlackBerry Ltd | John J. Giamatteo | Director, CEO & President, Secure Comm. | Sale of securities on an exchange or to another person at price $ 3.88 per share. | 06 Jan 2026 | 29,739 | 859,840 (0%) | 0% | 3.9 | 115,387 | Common Shares |
| Amplify Energy Corp | Eric M. Willis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 29,462 | 252,215 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Amplify Energy Corp | Eric M. Willis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 29,462 | 96,009 | - | - | Performance Stock Units | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 29,000 | 29,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Paul F. Lizzul | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 29,000 | 29,000 | - | - | Stock Option (right to buy) | |
| Broadcom | Hock E. Tan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 346.75 per share. | 06 Jan 2026 | 27,199 | 175,637 (0%) | 0% | 346.8 | 9,431,308 | Common Stock, $0.001 par value |
| Maze Therapeutics Inc | Catherine Angell Sohn | Director | Sale of securities on an exchange or to another person at price $ 39.11 per share. | 06 Jan 2026 | 26,920 | 0 | - | 39.1 | 1,052,785 | Common Stock |
| Compass Inc (Class A) | Scott Wahlers | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 26,393 | 290,331 | - | - | Restricted Stock Unit (RSU) | |
| Mission Produce Inc | Joanne C. Wu | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 25,181 | 99,479 | - | 0 | COMMON STOCK | |
| Cloudastructure Inc (Class A) | Richard Bentley | Ten Percent Owner, Founder | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 06 Jan 2026 | 25,000 | 75,000 | - | 0.9 | 21,250 | Class A Common Stock |
| Cloudastructure Inc (Class A) | Richard Bentley | Ten Percent Owner, Founder | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 06 Jan 2026 | 25,000 | 50,000 | - | 0.9 | 21,250 | Class A Common Stock |
| Broadcom | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale of securities on an exchange or to another person at price $ 346.99 per share. | 06 Jan 2026 | 24,113 | 216,460 (0%) | 0% | 347.0 | 8,367,018 | Common Stock, $0.001 par value |
| Amplify Energy Corp | James G. Frew | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.57 per share. | 06 Jan 2026 | 23,888 | 161,163 (0%) | 0% | 4.6 | 109,168 | Common Stock, par value $0.01 per share |
| Amplify Energy Corp | Daniel Furbee | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.57 per share. | 06 Jan 2026 | 23,878 | 81,189 (0%) | 0% | 4.6 | 109,122 | Common Stock, par value $0.01 per share |
| Hecla Mining Co. | Kurt D. Allen | VP-Exploration | Other type of transaction at price $ 0.00 per share. | 06 Jan 2026 | 23,774 | 23,774 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.82 per share. | 06 Jan 2026 | 23,766 | 323,530 (0%) | 0% | 6.8 | 162,077 | Common Stock |
| CRISPR Therapeutics AG | Raju Prasad | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.15 per share. | 06 Jan 2026 | 23,361 | 30,128 (0%) | 0% | 45.1 | 1,054,749 | Common Shares |
| CRISPR Therapeutics AG | Raju Prasad | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 23,361 | 76,639 | - | - | Stock Option (Right to Buy) | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 23,200 | 23,200 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 21,400 | 21,400 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Paul F. Lizzul | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 21,400 | 21,400 | - | - | Restricted Stock Unit | |
| Sailpoint Inc | Matt Mills | President | Sale of securities on an exchange or to another person at price $ 19.23 per share. | 06 Jan 2026 | 21,345 | 1,882,913 | - | 19.2 | 410,484 | Common Stock |
| EyePoint Pharma Inc | Jay S. Duker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 20,793 | 0 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Jay S. Duker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 20,793 | 87,806 (0%) | 0% | 0 | Common Stock | |
| Maze Therapeutics Inc | Catherine Angell Sohn | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.42 per share. | 06 Jan 2026 | 20,744 | 20,744 | - | 10.4 | 216,152 | Common Stock |
| Maze Therapeutics Inc | Catherine Angell Sohn | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 20,744 | 0 | - | - | Stock Option (Right to Buy) | |
| Hurco Companies Inc | Sonja K. Mcclelland | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 20,718 | 119,398 (1%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | William Guyer | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.65 per share. | 06 Jan 2026 | 20,000 | 21,235 (0%) | 0% | 21.7 | 433,000 | Common Stock |
| Corcept Therapeutics Inc | William Guyer | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 35.18 per share. | 06 Jan 2026 | 20,000 | 1,235 (0%) | 0% | 35.2 | 703,656 | Common Stock |
| Corcept Therapeutics Inc | William Guyer | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 20,000 | 250,000 | - | - | Stock option (right to buy) | |
| Transcat Inc | Thomas L. Barbato | Sr. VP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 19,772 | 19,772 | - | - | Restricted Stock Units | |
| EverCommerce Inc | Eric Remer | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.52 per share. | 06 Jan 2026 | 19,200 | 2,760,818 | - | 11.5 | 221,253 | Common Stock |
| CRISPR Therapeutics AG | Raju Prasad | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.18 per share. | 06 Jan 2026 | 18,933 | 17,534 (0%) | 0% | 60.2 | 1,139,386 | Common Shares |
| APA | Kimberly O. Warnica | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 18,320 | 36,265 | - | - | Restricted Stock / Units | |
| APA | Ben C. Rodgers | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 18,320 | 27,706 | - | - | Restricted Stock / Units | |
| APA | Tracey K. Henderson | Executive VP Exploration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 18,320 | 59,089 | - | - | Restricted Stock / Units | |
| APA | Mark D Maddox | Executive VP - Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 18,320 | 52,855 | - | - | Restricted Stock / Units | |
| Sailpoint Inc | Matt Mills | President | Sale of securities on an exchange or to another person at price $ 19.90 per share. | 06 Jan 2026 | 18,159 | 1,864,754 | - | 19.9 | 361,415 | Common Stock |
| Puma biotech Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.88 per share. | 06 Jan 2026 | 18,012 | 7,145,951 (18%) | 0% | 5.9 | 105,893 | Common Stock |
| AnaptysBio Inc | Daniel R. Faga | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 17,850 | 17,850 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Daniel R. Faga | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 17,850 | 475,989 (1%) | 0% | - | Common Stock | |
| Sprott Focus Trust Inc | W. Whitney George | Director, Ten Percent Owner, Senior Portfolio Manager | Sale of securities on an exchange or to another person at price $ 8.85 per share. | 06 Jan 2026 | 17,700 | 306,805 (1%) | 0% | 8.9 | 156,645 | Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 75.32 per share. | 06 Jan 2026 | 17,670 | 5,895,444 | - | 75.3 | 1,330,874 | Class A Common Stock |
| Mission Produce Inc | Bryan E. Giles | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.79 per share. | 06 Jan 2026 | 17,621 | 151,931 | - | 11.8 | 207,752 | COMMON STOCK |
| Amplify Energy Corp | Anthony William Lopez | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 17,397 | 157,818 (0%) | 0% | - | Common Stock, par value $0.01 per share | |
| Amplify Energy Corp | Anthony William Lopez | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 17,397 | 70,865 | - | - | Performance Stock Units | |
| Rivian Automotive Inc (Class A) | Robert J. Scaringe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.54 per share. | 06 Jan 2026 | 17,350 | 1,132,759 | - | 19.5 | 339,062 | Class A Common Stock |
| Denali Therapeutics Inc | Alexander O. Schuth | COFO and Secretary | Sale of securities on an exchange or to another person at price $ 16.50 per share. | 06 Jan 2026 | 17,218 | 282,828 (0%) | 0% | 16.5 | 284,097 | Common Stock |
| Mission Produce Inc | John M. Pawlowski | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 17,105 | 86,482 | - | 0 | COMMON STOCK | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 17,100 | 17,100 | - | - | Restricted Stock Unit | |
| Puma biotech Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.84 per share. | 06 Jan 2026 | 16,938 | 7,163,963 (18%) | 0% | 5.8 | 98,986 | Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 203.13 per share. | 06 Jan 2026 | 16,653 | 7,775 (0%) | 0% | 203.1 | 3,382,754 | Class A Common Stock |
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Co-Chief Executive Officer, Ten Percent Owner | 06 Jan 2026 | 16,649 | 16,649 | - | - | Series A Common Stock | ||
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Co-Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.01 per share. | 06 Jan 2026 | 16,649 | 0 | - | 30.0 | 499,636 | Series A Common Stock |
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Co-Chief Executive Officer, Ten Percent Owner | 06 Jan 2026 | 16,649 | 69,414,736 | - | - | Series B Common Stock | ||
| Alignment Healthcare Inc | Hyong Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.35 per share. | 06 Jan 2026 | 16,506 | 333,133 | - | 21.3 | 352,357 | Common Stock |
| APA | Robert P. Rayphole | VP CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 16,384 | 16,384 | - | - | Stock Option Grant | |
| EyePoint Pharma Inc | George O. Elston | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 15,285 | 96,339 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | George O. Elston | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 15,285 | 0 | - | - | Restricted Stock Units | |
| Sailpoint Inc | Brian Carolan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.23 per share. | 06 Jan 2026 | 15,234 | 1,321,394 | - | 19.2 | 292,964 | Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 75.34 per share. | 06 Jan 2026 | 15,213 | 252,390 | - | 75.3 | 1,146,157 | Class A Common Stock |
| Sinclair Inc (Class A) | Howard E. Friedman | Director | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 06 Jan 2026 | 14,713 | 77,685 (0%) | 0% | 15.1 | 222,313 | Class A Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 193.16 per share. | 06 Jan 2026 | 14,358 | 27,360 (0%) | 0% | 193.2 | 2,773,368 | Class A Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 187.46 per share. | 06 Jan 2026 | 14,219 | 34,350 (0%) | 0% | 187.5 | 2,665,478 | Class A Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.40 per share. | 06 Jan 2026 | 13,949 | 5,868,004 | - | 77.4 | 1,079,655 | Class A Common Stock |
| Sailpoint Inc | Matt Mills | President | Sale of securities on an exchange or to another person at price $ 19.57 per share. | 06 Jan 2026 | 13,771 | 1,850,983 | - | 19.6 | 269,514 | Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 77.47 per share. | 06 Jan 2026 | 13,538 | 227,530 | - | 77.5 | 1,048,811 | Class A Common Stock |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 76.29 per share. | 06 Jan 2026 | 13,491 | 5,881,953 | - | 76.3 | 1,029,241 | Class A Common Stock |
| Amplify Energy Corp | Eric M. Willis | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.57 per share. | 06 Jan 2026 | 13,155 | 239,060 (0%) | 0% | 4.6 | 60,118 | Common Stock, par value $0.01 per share |
| Sailpoint Inc | Brian Carolan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.90 per share. | 06 Jan 2026 | 12,961 | 1,308,433 | - | 19.9 | 257,960 | Common Stock |
| F.N.B. Corp | Vincent J. Delie | Director, Chairman, President, & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.19 per share. | 06 Jan 2026 | 12,725 | 1,910,216 (0%) | 0% | 17.2 | 218,743 | Common Stock |
| Mission Produce Inc | Joanne C. Wu | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.79 per share. | 06 Jan 2026 | 12,650 | 86,829 | - | 11.8 | 149,144 | COMMON STOCK |
| Anavex Life Sciences Corp | Sandra Boenisch | PFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Zspace Inc | Paul Kellenberger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 06 Jan 2026 | 12,453 | 64,785 | - | 0.5 | 6,500 | Common Stock |
| FreightCar America Inc | Matthew W. Tonn | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.76 per share. | 06 Jan 2026 | 12,328 | 239,151 (1%) | 0% | 10.8 | 132,649 | Common Stock |
| PubMatic Inc Ordinary Shares | Paulina Klimenko | CHIEF GROWTH OFFICER | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 06 Jan 2026 | 12,315 | 51,780 | - | 8.7 | 107,509 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Jesse Timmermans | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 12,053 | 23,663 (0%) | 0% | 0 | Class A Common Stock | |
| Revolve Grp Inc (Class A) | Jesse Timmermans | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.51 per share. | 06 Jan 2026 | 12,053 | 11,610 (0%) | 0% | 31.5 | 379,790 | Class A Common Stock |
| Transcat Inc | Michael W. West | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 12,028 | 12,028 | - | - | Restricted Stock Units | |
| Sailpoint Inc | Christopher Schmitt | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 19.23 per share. | 06 Jan 2026 | 11,908 | 1,057,956 | - | 19.2 | 229,002 | Common Stock |
| SentinelOne Inc (Class A) | Ana G. Pinczuk | Director, President Product & Technology | Sale of securities on an exchange or to another person at price $ 14.82 per share. | 06 Jan 2026 | 11,900 | 560,589 | - | 14.8 | 176,358 | Class A Common Stock |
| Matador Resources Co | Joseph Wm. Foran | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 11,600 | 35,652 (0%) | 0% | 0 | Common Stock | |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 188.33 per share. | 06 Jan 2026 | 11,553 | 22,797 (0%) | 0% | 188.3 | 2,175,813 | Class A Common Stock |
| General Mills | Paul J. Gallagher | Chief Supply Chain Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 11,406 | 59,974 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.26 per share. | 06 Jan 2026 | 11,340 | 43,210 (0%) | 0% | 59.3 | 671,971 | Common Stock |
| Edwards Lifesciences | Donald E. Bobo | CVP,Strategy/Corp Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 11,340 | 34,020 | - | - | Employee Stock Option (Right to Acquire) | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 76.32 per share. | 06 Jan 2026 | 11,322 | 241,068 | - | 76.3 | 864,114 | Class A Common Stock |
| SentinelOne Inc (Class A) | Barbara A. Larson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.82 per share. | 06 Jan 2026 | 11,173 | 539,372 | - | 14.8 | 165,584 | Class A Common Stock |
| Arteris Inc | K. Charles Janac | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.90 per share. | 06 Jan 2026 | 11,145 | 139,487 | - | 16.9 | 188,386 | Common Stock |
| FreightCar America Inc | Michael Anthony Riordan | VP Finance, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.76 per share. | 06 Jan 2026 | 11,133 | 155,426 (1%) | 0% | 10.8 | 119,791 | Common Stock |
| Twilio Inc (Class A) | Khozema Z. Shipchandler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 134.50 per share. | 06 Jan 2026 | 11,123 | 193,813 (0%) | 0% | 134.5 | 1,495,992 | Class A Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 200.31 per share. | 06 Jan 2026 | 11,057 | 32,618 (0%) | 0% | 200.3 | 2,214,782 | Class A Common Stock |
| Sailpoint Inc | Abby Payne | Chief People Officer | Sale of securities on an exchange or to another person at price $ 19.23 per share. | 06 Jan 2026 | 10,965 | 691,718 | - | 19.2 | 210,867 | Common Stock |
| Sunrun Inc | Danny Abajian | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 10,858 | 394,660 (0%) | 0% | 0 | Common Stock | |
| Sunrun Inc | Danny Abajian | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2026 | 10,858 | 222,355 (0%) | 0% | 0 | Common Stock | |
| Incyte | Mohamed Khairie Issa | EVP, Head of US Oncology | Sale of securities on an exchange or to another person at price $ 109.07 per share. | 06 Jan 2026 | 10,856 | 66,132 (0%) | 0% | 109.1 | 1,184,064 | Common Stock |
| Iridium Comm Inc | Louis M. Alterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 10,822 | 13,698 (0%) | 0% | 0 | Common Stock | |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 197.22 per share. | 06 Jan 2026 | 10,798 | 3,746 (0%) | 0% | 197.2 | 2,129,599 | Class A Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 192.33 per share. | 06 Jan 2026 | 10,666 | 41,718 (0%) | 0% | 192.3 | 2,051,410 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 06 Jan 2026 | 10,600 | 89,400 | - | 34.0 | 360,327 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 06 Jan 2026 | 10,600 | 89,400 | - | 34.0 | 360,335 | Class A Common Stock |
| Cartesian Therapeutics Inc | Blaine Davis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.82 per share. | 06 Jan 2026 | 10,591 | 121,220 (0%) | 0% | 6.8 | 72,227 | Common Stock |
| Transcat Inc | Theresa Conroy | Sr. VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 10,380 | 10,380 | - | - | Restricted Stock Units | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 76.47 per share. | 06 Jan 2026 | 10,253 | 144,226 | - | 76.5 | 784,028 | Class A Common Stock |
| Odyssey Marine Exploration Inc | Larissa T. Pommeraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 10,204 | 36,549 (0%) | 0% | 0 | Common Stock | |
| Sailpoint Inc | Christopher Schmitt | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 19.90 per share. | 06 Jan 2026 | 10,130 | 1,047,826 | - | 19.9 | 201,615 | Common Stock |
| EyePoint Pharma Inc | Jay S. Duker | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.86 per share. | 06 Jan 2026 | 10,054 | 77,752 (0%) | 0% | 16.9 | 169,510 | Common Stock |
| APA | Robert P. Rayphole | VP CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 10,034 | 18,336 | - | - | Restricted Stock / Units | |
| Lemonade Inc | John Peters | Chief Insurance Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 06 Jan 2026 | 10,000 | 60,771 | - | 80 | 800,000 | COMMON STOCK |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.44 per share. | 06 Jan 2026 | 10,000 | 1,222,312 (0%) | 0% | 16.4 | 164,400 | Common Stock |
| Grid Dynamics Holdings Inc (Class A) | Leonard Livschitz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 9.70 per share. | 06 Jan 2026 | 10,000 | 3,134,343 | - | 9.7 | 97,000 | Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.77 per share. | 06 Jan 2026 | 9,971 | 384,700 | - | 34.8 | 346,689 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.77 per share. | 06 Jan 2026 | 9,908 | 384,700 | - | 34.8 | 344,512 | Class A Common Stock |
| ZipRecruiter Inc (Class A) | Ian Siegel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 06 Jan 2026 | 9,730 | 82,228 | - | 3.7 | 36,000 | Class A Common Stock |
| Broadcom | Hock E. Tan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 348.28 per share. | 06 Jan 2026 | 9,723 | 132,836 (0%) | 0% | 348.3 | 3,386,326 | Common Stock, $0.001 par value |
| ZipRecruiter Inc (Class A) | Ian Siegel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 06 Jan 2026 | 9,722 | 72,506 | - | 3.6 | 34,709 | Class A Common Stock |
| ZipRecruiter Inc (Class A) | Ian Siegel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.38 per share. | 06 Jan 2026 | 9,722 | 62,784 | - | 3.4 | 32,841 | Class A Common Stock |
| Hecla Mining Co. | Kurt D. Allen | VP-Exploration | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 06 Jan 2026 | 9,560 | 259,300 (0%) | 0% | 22.0 | 210,353 | Common Stock |
| Vertex Pharma | Charles F. Wagner | EVP, CO & FO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 189.38 per share. | 06 Jan 2026 | 9,532 | 47,257 (0%) | 0% | 189.4 | 1,805,170 | Common Stock |
| Vertex Pharma | Charles F. Wagner | EVP, CO & FO | Sale of securities on an exchange or to another person at price $ 461.00 per share. | 06 Jan 2026 | 9,532 | 37,725 (0%) | 0% | 461 | 4,394,252 | Common Stock |
| Vertex Pharma | Charles F. Wagner | EVP, CO & FO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 9,532 | 0 | - | - | Stock Option (Right to Buy) | |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 74.40 per share. | 06 Jan 2026 | 9,506 | 5,913,114 | - | 74.4 | 707,204 | Class A Common Stock |
| Mission Produce Inc | Damian Ricketts | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 9,442 | 18,102 | - | 0 | COMMON STOCK | |
| Sailpoint Inc | Abby Payne | Chief People Officer | Sale of securities on an exchange or to another person at price $ 19.90 per share. | 06 Jan 2026 | 9,329 | 682,389 | - | 19.9 | 185,673 | Common Stock |
| AnaptysBio Inc | Daniel R. Faga | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 45.11 per share. | 06 Jan 2026 | 9,202 | 466,787 (1%) | 0% | 45.1 | 415,102 | Common Stock |
| Sunrun Inc | Mary G. Powell | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 06 Jan 2026 | 8,754 | 864,946 (0%) | 0% | 17.8 | 155,784 | Common Stock |
| Edwards Lifesciences | Donald E. Bobo | CVP,Strategy/Corp Development | Sale of securities on an exchange or to another person at price $ 85.98 per share. | 06 Jan 2026 | 8,708 | 31,870 (0%) | 0% | 86.0 | 748,708 | Common Stock |
| Insmed Inc | Martina Flammer | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.43 per share. | 06 Jan 2026 | 8,570 | 103,324 (0%) | 0% | 26.4 | 226,505 | Common Stock |
| Insmed Inc | Martina Flammer | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 8,570 | 0 | - | - | Stock Option (right to buy) | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 74.41 per share. | 06 Jan 2026 | 8,450 | 267,603 | - | 74.4 | 628,797 | Class A Common Stock |
| Incyte | Mohamed Khairie Issa | EVP, Head of US Oncology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.66 per share. | 06 Jan 2026 | 8,264 | 76,988 (0%) | 0% | 106.7 | 881,438 | Common Stock |
| AnaptysBio Inc | John A. Orwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 8,250 | 8,250 | - | - | Stock Option (right to buy) | |
| Surrozen Inc | Tim Kutzkey | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.89 per share. | 06 Jan 2026 | 8,003 | 989,893 | - | 19.9 | 159,157 | Common Stock |
| Murphy USA Inc | Mindy K. West | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.15 per share. | 06 Jan 2026 | 8,000 | 125,388 (0%) | 0% | 76.2 | 609,200 | Common Stock |
| Murphy USA Inc | Mindy K. West | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 8,000 | 0 | - | - | Stock Option | |
| Coastal Fin Corp | Sprink M Eric | Director, CEO | Sale of securities on an exchange or to another person at price $ 116.35 per share. | 06 Jan 2026 | 8,000 | 185,884 (1%) | 0% | 116.3 | 930,794 | Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 204.17 per share. | 06 Jan 2026 | 7,775 | 0 (0%) | 0% | 204.2 | 1,587,443 | Class A Common Stock |
| Amplify Energy Corp | Anthony William Lopez | SEE REMARKS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.57 per share. | 06 Jan 2026 | 7,768 | 150,050 (0%) | 0% | 4.6 | 35,500 | Common Stock, par value $0.01 per share |
| Amylyx Pharma Inc | Joshua Cohen | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.09 per share. | 06 Jan 2026 | 7,715 | 3,317,632 | - | 11.1 | 85,596 | Common Stock |
| Amylyx Pharma Inc | Justin Klee | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.09 per share. | 06 Jan 2026 | 7,715 | 3,317,586 | - | 11.1 | 85,589 | Common Stock |
| Restaurant Brands Intl Inc | J. Patrick Doyle | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 7,695 | 836,080 | - | - | Performance Share Units | |
| Odyssey Marine Exploration Inc | Todd E. Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 7,653 | 106,965 (1%) | 0% | 0 | Common Stock | |
| Sunrun Inc | Danny Abajian | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 06 Jan 2026 | 7,190 | 405,518 (0%) | 0% | 17.8 | 128,002 | Common Stock |
| PubMatic Inc Ordinary Shares | Amar K. Goel | Director, CHAIRMAN, CHIEF INNOVATION OFF, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 06 Jan 2026 | 7,158 | 12,496 | - | 8.7 | 62,510 | Class A Common Stock |
| Surrozen Inc | Tim Kutzkey | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.89 per share. | 06 Jan 2026 | 7,097 | 876,557 | - | 19.9 | 141,139 | Common Stock |
| Yelp Inc | Joseph R. Nachman | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.34 per share. | 06 Jan 2026 | 7,000 | 188,880 (0%) | 0% | 33.3 | 233,360 | Common Stock |
| ARMOUR Residential REIT Inc | Robert C. Hain | Director | Sale of securities on an exchange or to another person at price $ 18.06 per share. | 06 Jan 2026 | 6,833 | 1,010 (0%) | 0% | 18.1 | 123,435 | Common Stock, par value $0.001 per share |
| CoreWeave Inc (Class A) | Michael Intrator | Director, CEO and President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 77.96 per share. | 06 Jan 2026 | 6,770 | 5,861,234 | - | 78.0 | 527,776 | Class A Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 190.42 per share. | 06 Jan 2026 | 6,518 | 11,832 (0%) | 0% | 190.4 | 1,241,182 | Class A Common Stock |
| Puma biotech Inc | Maximo F. Nougues | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.88 per share. | 06 Jan 2026 | 6,405 | 193,284 (0%) | 0% | 5.9 | 37,655 | Common Stock |
| CRISPR Therapeutics AG | Raju Prasad | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.31 per share. | 06 Jan 2026 | 6,339 | 36,467 (0%) | 0% | 44.3 | 280,881 | Common Shares |
| CRISPR Therapeutics AG | Raju Prasad | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 6,339 | 7,493 | - | - | Stock Option (Right to Buy) | |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 196.35 per share. | 06 Jan 2026 | 6,337 | 14,544 (0%) | 0% | 196.4 | 1,244,274 | Class A Common Stock |
| Zspace Inc | Erick DeOliveira | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 06 Jan 2026 | 6,320 | 42,016 | - | 0.5 | 3,299 | Common Stock |
| AnaptysBio Inc | Paul F. Lizzul | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 6,145 | 6,145 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Paul F. Lizzul | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 6,145 | 39,448 (0%) | 0% | - | Common Stock | |
| Sunrun Inc | Paul S. Dickson | Pres. & Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 06 Jan 2026 | 6,119 | 639,110 (0%) | 0% | 17.8 | 108,905 | Common Stock |
| Monarch Casino & Resort Inc | Yvette E. Landau | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Jan 2026 | 6,100 | 48,800 | - | - | Options / Right to Buy | |
| Revolve Grp Inc (Class A) | Jesse Timmermans | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 6,033 | 41,095 | - | - | Stock Option (right to buy) | |
| Revolve Grp Inc (Class A) | Jesse Timmermans | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 6,020 | 3,480 | - | - | Stock Option (right to buy) | |
| Home Federal Bancorp Inc (Louisiana) | Timothy W. Wilhite | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.86 per share. | 06 Jan 2026 | 6,000 | 48,896 (2%) | 0% | 11.9 | 71,160 | Common Stock |
| Home Federal Bancorp Inc (Louisiana) | Timothy W. Wilhite | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 6,000 | 12,000 | - | - | Stock Options (Right to Buy) | |
| AnaptysBio Inc | John A. Orwin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 6,000 | 6,000 | - | - | Restricted Stock Unit | |
| Broadcom | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Sale of securities on an exchange or to another person at price $ 347.66 per share. | 06 Jan 2026 | 5,887 | 210,573 (0%) | 0% | 347.7 | 2,046,674 | Common Stock, $0.001 par value |
| Matador Resources Co | Van H. Singleton | CoPresident-Land, A&D,Planning | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,800 | 298,890 (0%) | 0% | 0 | Common Stock | |
| Matador Resources Co | G. Gregg Krug | EVP - Mktg and Midstream | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,800 | 232,166 (0%) | 0% | 0 | Common Stock | |
| CRISPR Therapeutics AG | Raju Prasad | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.21 per share. | 06 Jan 2026 | 5,763 | 6,767 (0%) | 0% | 60.2 | 347,010 | Common Shares |
| Hurco Companies Inc | Jonathon D. Wright | General Counsel/Corp Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,718 | 15,718 (0%) | 0% | 0 | Common Stock | |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 202.58 per share. | 06 Jan 2026 | 5,647 | 24,428 (0%) | 0% | 202.6 | 1,143,987 | Class A Common Stock |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 5,545 | 18,796 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 5,545 | 5,545 | - | - | Restricted Stock Unit | |
| OneStream Inc (Class A) | Jonathan D. Mariner | Director | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 06 Jan 2026 | 5,541 | 7,130 | - | 23.6 | 130,712 | Class A Common Stock |
| Hurco Companies Inc | HaiQuynh Jamison | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,525 | 15,879 (0%) | 0% | 0 | Common Stock | |
| Sun Country Airlines Holdings Inc | Jude I. Bricker | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.97 per share. | 06 Jan 2026 | 5,514 | 173,044 | - | 15.0 | 82,556 | Common Stock, par value $0.01 per share |
| AnaptysBio Inc | Dennis M. Fenton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Hollings C. Renton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| ABM Ind Inc | Sudhakar Kesavan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,366 | 52,577 (0%) | 0% | 0 | Common Stock | |
| Revolve Grp Inc (Class A) | Jesse Timmermans | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 5,349 | 16,959 (0%) | 0% | 0 | Class A Common Stock | |
| Revolve Grp Inc (Class A) | Jesse Timmermans | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.51 per share. | 06 Jan 2026 | 5,349 | 11,610 (0%) | 0% | 31.5 | 168,547 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Jesse Timmermans | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 5,349 | 35,346 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Eric J. Loumeau | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.38 per share. | 06 Jan 2026 | 5,281 | 11,498 (0%) | 0% | 45.4 | 239,672 | Common Stock |
| FreightCar America Inc | Juan Carlos Fuentes Sierra | Corporate Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.76 per share. | 06 Jan 2026 | 5,266 | 41,384 (0%) | 0% | 10.8 | 56,662 | Common Stock |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 5,245 | 19,575 (0%) | 0% | - | Common Stock | |
| AnaptysBio Inc | Dennis M. Mulroy | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 5,245 | 5,245 | - | - | Restricted Stock Unit | |
| Transcat Inc | Michael Jacques Haddad | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,190 | 5,190 | - | - | Restricted Stock Units | |
| Hydrofarm Holdings Grp Inc | William Toler | Director, Chief Executive Officer, Executive Chairman of Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.51 per share. | 06 Jan 2026 | 5,189 | 221,672 | - | 1.5 | 7,835 | Common Stock, $0.0001 par value per share |
| PTC Therapeutics Inc | Matthew B. Klein | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 76.95 per share. | 06 Jan 2026 | 5,149 | 399,983 (0%) | 0% | 77.0 | 396,216 | Common Stock |
| Sailpoint Inc | Chandrasekar Gnanasambandam | EVP Product & CTO | Sale of securities on an exchange or to another person at price $ 19.23 per share. | 06 Jan 2026 | 5,124 | 525,956 | - | 19.2 | 98,539 | Common Stock |
| Puma biotech Inc | Douglas M. Hunt | See Remarks | Sale of securities on an exchange or to another person at price $ 5.88 per share. | 06 Jan 2026 | 5,014 | 155,907 (0%) | 0% | 5.9 | 29,477 | Common Stock |
| Mission Produce Inc | John M. Pawlowski | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.66 per share. | 06 Jan 2026 | 5,005 | 69,377 | - | 11.7 | 58,358 | COMMON STOCK |
| CRISPR Therapeutics AG | Raju Prasad | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 06 Jan 2026 | 5,004 | 12,530 (0%) | 0% | 60 | 300,240 | Common Shares |
| Merit Medical Systems Inc | Neil W. Peterson | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.40 per share. | 06 Jan 2026 | 5,000 | 33,369 (0%) | 0% | 54.4 | 272,000 | Common Stock, No Par Value |
| Merit Medical Systems Inc | Neil W. Peterson | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 06 Jan 2026 | 5,000 | 28,369 (0%) | 0% | 90 | 450,000 | Common Stock, No Par Value |
| Merit Medical Systems Inc | Neil W. Peterson | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 5,000 | 0 | - | - | Non-qualified stock options (right to buy) | |
| WaterBridge Infrastructure | Michael Howard Reitz | See Remarks | Purchase of securities on an exchange or from another person at price $ 20.49 per share. | 06 Jan 2026 | 4,865 | 99,865 | - | 20.5 | 99,684 | Class A shares |
| Matador Resources Co | Joseph Wm. Foran | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.41 per share. | 06 Jan 2026 | 4,798 | 30,854 (0%) | 0% | 41.4 | 198,685 | Common Stock |
| Insmed Inc | Martina Flammer | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 173.47 per share. | 06 Jan 2026 | 4,783 | 98,541 (0%) | 0% | 173.5 | 829,707 | Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 191.29 per share. | 06 Jan 2026 | 4,627 | 7,205 (0%) | 0% | 191.3 | 885,087 | Class A Common Stock |
| BlackBerry Ltd | Tim Foote | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 4,616 | 27,007 | - | - | Performance-Based Restricted Share Units | |
| BlackBerry Ltd | Tim Foote | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2026 | 4,616 | 64,419 (0%) | 0% | - | Common Shares | |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 199.32 per share. | 06 Jan 2026 | 4,610 | 43,675 (0%) | 0% | 199.3 | 918,854 | Class A Common Stock |
| Zspace Inc | Michael S. Harper | See remarks | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 06 Jan 2026 | 4,550 | 38,397 | - | 0.5 | 2,375 | Common Stock |
| Puma biotech Inc | Maximo F. Nougues | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.84 per share. | 06 Jan 2026 | 4,540 | 199,689 (0%) | 0% | 5.8 | 26,532 | Common Stock |
| Sailpoint Inc | Christopher Schmitt | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 19.57 per share. | 06 Jan 2026 | 4,507 | 1,043,319 | - | 19.6 | 88,207 | Common Stock |
| Nasdaq | John A. Zecca | EVP, Global CLO | Sale of securities on an exchange or to another person at price $ 100.01 per share. | 06 Jan 2026 | 4,500 | 125,674 (0%) | 0% | 100.0 | 450,045 | Common Stock, par value $0.01 per share |
| Sailpoint Inc | Mitra Rezvan | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 19.23 per share. | 06 Jan 2026 | 4,491 | 126,712 | - | 19.2 | 86,366 | Common Stock |
| EyePoint Pharma Inc | George O. Elston | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.86 per share. | 06 Jan 2026 | 4,487 | 91,852 (0%) | 0% | 16.9 | 75,651 | Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 189.16 per share. | 06 Jan 2026 | 4,447 | 18,350 (0%) | 0% | 189.2 | 841,175 | Class A Common Stock |
| Mission Produce Inc | Damian Ricketts | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.79 per share. | 06 Jan 2026 | 4,446 | 13,656 | - | 11.8 | 52,418 | COMMON STOCK |
| Sunrun Inc | Jeanna Steele | Chief Legal & People Officer | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 06 Jan 2026 | 4,430 | 355,489 (0%) | 0% | 17.8 | 78,842 | Common Stock |
| Sailpoint Inc | Chandrasekar Gnanasambandam | EVP Product & CTO | Sale of securities on an exchange or to another person at price $ 19.90 per share. | 06 Jan 2026 | 4,360 | 521,596 | - | 19.9 | 86,776 | Common Stock |
| Sailpoint Inc | Chandrasekar Gnanasambandam | EVP Product & CTO | Sale of securities on an exchange or to another person at price $ 19.57 per share. | 06 Jan 2026 | 4,245 | 517,351 | - | 19.6 | 83,079 | Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 195.27 per share. | 06 Jan 2026 | 4,118 | 20,881 (0%) | 0% | 195.3 | 804,107 | Class A Common Stock |
| Cloudflare Inc (Class A) | Matthew Prince | Director, CEO & Board Co-Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 198.50 per share. | 06 Jan 2026 | 4,099 | 48,285 (0%) | 0% | 198.5 | 813,635 | Class A Common Stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 173.33 per share. | 06 Jan 2026 | 4,096 | 320,987 (0%) | 0% | 173.3 | 709,960 | Common Stock |
| Reddit Inc (Class A) | Andrew Vollero | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 253.63 per share. | 06 Jan 2026 | 4,074 | 256,493 | - | 253.6 | 1,033,289 | Class A Common Stock |
| Murphy USA Inc | Mindy K. West | President & CEO | Sale of securities on an exchange or to another person at price $ 425.00 per share. | 06 Jan 2026 | 4,051 | 117,388 (0%) | 0% | 425 | 1,721,675 | Common Stock |
| AnaptysBio Inc | Dennis M. Fenton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Hollings C. Renton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | John Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Magda Marquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| ABM Ind Inc | Art A. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 3,996 | 35,248 (0%) | 0% | 0 | Common Stock | |
| ABM Ind Inc | LeighAnne G. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 3,996 | 21,588 (0%) | 0% | 0 | Common Stock | |
| ABM Ind Inc | Quincy L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 3,996 | 20,848 (0%) | 0% | 0 | Common Stock | |
| ABM Ind Inc | Thomas M. Gartland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 3,996 | 35,249 (0%) | 0% | 0 | Common Stock | |
| ABM Ind Inc | Webb Markus Winifred | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 3,996 | 44,781 (0%) | 0% | 0 | Common Stock | |
| ABM Ind Inc | James D. DeVries | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 3,996 | 15,879 (0%) | 0% | 0 | Common Stock | |
| ABM Ind Inc | Jill M. Golder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 3,996 | 19,077 (0%) | 0% | 0 | Common Stock | |
| ABM Ind Inc | Barry A. Hytinen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 3,996 | 4,921 (0%) | 0% | 0 | Common Stock | |
| ABM Ind Inc | Donald F. Colleran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 3,996 | 21,715 (0%) | 0% | 0 | Common Stock | |
| ABM Ind Inc | Carol Ann Clements | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 3,996 | 5,983 (0%) | 0% | 0 | Common Stock | |
| Puma biotech Inc | Douglas M. Hunt | See Remarks | Sale of securities on an exchange or to another person at price $ 5.84 per share. | 06 Jan 2026 | 3,973 | 160,921 (0%) | 0% | 5.8 | 23,218 | Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 78.02 per share. | 06 Jan 2026 | 3,950 | 223,580 | - | 78.0 | 308,192 | Class A Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.